title: Hafnia alvei endocarditis following pyelonephritis in a permanent pacemaker carrier.
authors.forename: Pierre
authors.initials: P
authors.lastname: Loulergue
authors.forename: Olivier
authors.initials: O
authors.lastname: Lortholary
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Mainardi
authors.forename: Marc
authors.initials: M
authors.lastname: Lecuit
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State / Q000382:microbiology; D020878:Device Removal; D017548:Echocardiography, Transesophageal; D004697:Endocarditis, Bacterial / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D004756:Enterobacteriaceae Infections / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D020611:Hafnia alvei / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial / Q000009:adverse effects / Q000382:microbiology*; D011704:Pyelonephritis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D012008:Recurrence; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents